Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05927818 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 25, 2024 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Site details revisedv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Istanbul University
115 trials monitored
See 1 trial at risk
Ovarian Cancer
1,336 trials monitored
See 90 trials at risk
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.
Trial Details
NCT Number NCT05927818
Lead Sponsor Istanbul University
Conditions
(from sponsor)		 Sentinel Lymph Node, Ovarian Carcinoma
Related terms Ovarian Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov